In the @ mg sonidegib group , @ ( @ % , @ % CI @-@ ) patients who achieved an objective response , as assessed by central review , were noted among the @ with locally advanced basal cell carcinoma and two ( @ % , @-@ ) among the @ with metastatic disease .